Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Takeda pledges support to HAE patients through its ‘Sunrise patient support program’ …
Gujarat Cancer and Research Institute (GCRI), a hub for advanced cancer treatment see…
'AMRIT' Retail Pharmacy scheme to provide affordable drugs for cancer & he…
Precision Meets Innovation: Robotic Surgery Enhances Success Rate in Knee Replacements …
IGIMS makes Aadhaar must Indira Gandhi Institute of Medical Sciences (IGIMS) has…
Bharat Aluminium Company Limited (BALCO). a Member of Vedanta Resources Pic is a lu l…
UTIITSL invites application for the following IT and Engineering jobs in the capacit…
Perimenopause Test: The Key to Early Detection Perimenopause is a transitional …
Bharat Aluminium Company Limited (BALCO), a Member of Vedanta Resources Pic is a full…
If you are searching for some best tips, hair care routine for hair loss, here a…